AI Deployment & Workflow
AI delivers value when agents are embedded in real work. USDM helps regulated teams deploy AI into intake triage, drafting, review, knowledge retrieval, evidence capture, and exception handling so work moves faster across Quality, Regulatory, Clinical, Manufacturing, Commercial/Medical, and IT/Ops.
AI in life sciences · life sciences AI consulting · AI consulting for pharma and biotech
USDM helps teams find the workflows where agents actually move the needle, then designs the operating model around them. That means identifying the right use cases, prioritizing where AI removes delay or rework, and shaping the workflow so the tech fits how regulated work really gets done.
AI governance life sciences · regulated AI · AI validation
The guardrails make the deployment usable in life sciences. USDM defines review points, human oversight, data boundaries, evidence capture, and validation expectations so AI workflows can be deployed safely and scaled without turning into chaos.
AI for quality, regulatory, PV, clinical, validation, CAPA, and deviation management
AI pays off when it improves specific business motions: intake triage, document generation and review, quality event support, regulatory intelligence, clinical ops support, manufacturing deviation workflows, knowledge retrieval, and evidence capture. USDM focuses on the workflows that speed up regulated work without losing control.
trusted AI · responsible AI · AI risk management · explainable AI
Trust is what keeps the workflow deployable after launch. USDM helps organizations monitor behavior, manage drift, preserve traceability, and keep human review in the loop so the AI stays useful as the work, models, and requirements change.
Meet the agent layer
USDM designs agents around bounded domain work: what the agent can draft, retrieve, summarize, route, or flag — and where a qualified human stays accountable. That is how AI becomes workflow, not theater with a login screen.
What it helps with
Deviation intake, CAPA starters, complaint triage, and evidence assembly.
Business outcome
Shorter quality queues with reviewable source context for the quality owner.
Meet the agentWhat it helps with
Change-impact packs, submission source gathering, commitment tracking, and Q&A prep.
Business outcome
Less document chasing and faster regulatory review without losing filing control.
Meet the agentWhat it helps with
Protocol support, site-startup follow-up, study trackers, and meeting actions.
Business outcome
Cleaner clinical coordination while sponsor and medical judgment stay human-owned.
Meet the agentWhat it helps with
Batch-record support, shift handoffs, exception triage, and production summaries.
Business outcome
Faster operational handoffs with release and disposition decisions still protected.
Meet the agentRecent AI resources
The newest USDM resources from the last 45 days covering AI readiness, agentic workflows, Claude governance, enterprise knowledge, and the controls needed to deploy AI in regulated life sciences work.
USDM and Glean help life sciences organizations deploy agentic AI workflows that are scalable, governed, and defensible in regulated GxP environments.
Read resourceA 90-day AI readiness assessment for life sciences: inventory use cases, classify risk, map data and platform controls, select pilots, and build a governed adoption roadmap.
Read resourceHow life sciences companies can govern Claude-supported agents in GxP workflows with scoped autonomy, human oversight, validation, monitoring, and change control.
Read resourceUSDM explains how Anthropic Claude can support regulated life sciences workflows when teams define intended use, governed context, human review, validation, and inspection-ready evidence.
Read resourceUSDM explains how life sciences teams can evaluate Claude Cowork as a governed work partner, not an unmanaged chatbot, with clear intended use, human review, and audit-ready controls.
Read resourceA practical USDM framework for Claude GxP validation: intended use, risk classification, data controls, human review, testing, monitoring, and change control for regulated AI adoption.
Read resourcePrompt patterns for regulated life sciences teams using Claude: frame intended use, ground responses in approved sources, require uncertainty handling, and preserve human review evidence.
Read resourceUSDM’s Layer 0-5 operating model for Claude adoption in life sciences: intended use, governed context, connectors, skills, agents, and evidence-based governance.
Read resourceA life sciences view of Claude connectors, Skills, and the Model Context Protocol as an integration layer that must be governed for access, evidence, validation, and change control.
Read resourceAI-assisted citizen development can bypass governance controls. Learn the cybersecurity, validation, and data risks life sciences organizations need to manage.
Read resourceUSDM explains why Glean's Work AI platform is a strong fit for life sciences and how the partnership helps regulated companies turn enterprise knowledge into action.
Read resourceLearn why data integration and interoperability are critical in life sciences, and how connected, standards-aligned data improves compliance, speed, visibility, and AI readiness.
Read resourceLearn how an AI Readiness Assessment helps life sciences organizations establish governance, validate AI systems, and scale adoption under GxP requirements and evolving FDA, EU AI Act, and ISO 42001 expectations.
Read resourceDeep dives
Explore detailed briefs on high-priority regulatory, compliance, and AI topics — each connecting USDM expertise to the specific challenges your organization faces.
AI Governance + Compliance
AI Governance + Compliance helps life sciences teams deploy AI through controlled workflows, validation discipline, and defensible oversight in regulated environments.
Read nowAI Strategy + Consulting
AI Strategy + Consulting helps life sciences organizations move from AI ambition to governed deployment, scalable workflows, and measurable operational value.
Read nowAI Trust, Risk, and Oversight
AI Trust, Risk, and Oversight gives life sciences organizations a practical way to deploy AI with accountability, explainability, and defensible controls.
Read nowApplied AI Use Cases
Applied AI Use Cases show how life sciences teams can deploy AI into quality, regulatory, clinical, and validation workflows without losing control or oversight.
Read nowFrequently Asked Questions
AI strategy is the structured plan for identifying, governing, implementing, and scaling AI in regulated environments. It matters because AI is already embedded in platforms and workflows, and unmanaged adoption is harder to govern or defend.
Regulated AI initiatives must align with GxP expectations, validation requirements, data governance standards, and evolving global regulations. Specialized consulting combines technical deployment with life sciences compliance and operational reality.
Executives should look for AI expertise plus deep life sciences domain knowledge, including regulated systems, data integrity, quality operations, validation, enterprise change management, readiness assessment, governance, and implementation support.
They prioritize use cases by value, system readiness, data readiness, and governance requirements, then move through readiness assessment, governance definition, focused pilots, validation of results, and scaled workflow deployment.
Major risks include poor governance, unclear intended use, weak data controls, lack of validation planning, vendor overreliance, model drift, explainability gaps, auditability gaps, and unclear accountability.
Success should be measured through business and compliance outcomes: reduced cycle times, lower compliance costs, faster decisions, stronger inspection readiness, clearer AI ownership, better governance maturity, and scalable operations.
AI strategy only creates value when it turns into controlled workflows teams can actually use. The work has to connect business priorities, process design, change management, data readiness, and deployment planning.
Good consulting combines domain knowledge, regulatory awareness, workflow redesign, and validated systems so AI deployment improves execution without breaking compliance.
When AI influences quality, regulatory, clinical, or manufacturing work, organizations need controls around inputs, outputs, review, traceability, and change so the workflow remains governed and defensible.
Trust comes from visibility, review discipline, and continuous oversight. Teams need clear intervention points, documented exception handling, and monitoring that shows the workflow still behaves as intended over time.
Talk to an AI specialist
USDM helps life sciences organizations deploy AI that is validated, traceable, and defensible — not just functional.
